Welcome to LookChem.com Sign In|Join Free

CAS

  • or

183499-56-1

Post Buying Request

183499-56-1 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

183499-56-1 Usage

Chemical structure

A complex compound with a piperazinone core and two chloride ions.

Core component

Piperazinone.

Chloride ions

Contains two chloride ions for every molecule of the compound.

3-chlorophenyl group

A phenyl group with a chlorine atom at the 3rd position.

4-cyanobenzyl group

A benzyl group with a cyano group at the 4th position on the benzene ring.

5-imidazolylmethyl group

An imidazolyl group with a methyl group attached to the 5th position.

Potential applications

May have pharmaceutical or biological applications.

Imidazolylmethyl and piperazinone groups

Commonly found in drug molecules.

Further research

Additional testing and research would be necessary to fully understand the properties and potential uses of this chemical.

Check Digit Verification of cas no

The CAS Registry Mumber 183499-56-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,8,3,4,9 and 9 respectively; the second part has 2 digits, 5 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 183499-56:
(8*1)+(7*8)+(6*3)+(5*4)+(4*9)+(3*9)+(2*5)+(1*6)=181
181 % 10 = 1
So 183499-56-1 is a valid CAS Registry Number.

183499-56-1Downstream Products

183499-56-1Relevant articles and documents

Method of treating cancer

-

Page/Page column 95, (2010/02/12)

The present invention relates to methods of treating cancer using a combination of a compound which is an antineoplastic agent and a compound which is a inhibitor of prenyl-protein transferase, which methods comprise administering to said mammal, either s

INHIBITORS OF FARNESYL-PROTEIN TRANSFERASE

-

, (2008/06/13)

The present invention is directed to compounds which inhibit farnesyl-protein transferase (FTase) and the farnesylation of the oncogene protein Ras. The invention is further directed to chemotherapeutic compositions containing the compounds of this invention and methods for inhibiting farnesyl-protein transferase and the farnesylation of the oncogene protein Ras

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 183499-56-1